Literature DB >> 11785672

Enforced expression of Bcl-2 selectively perturbs negative selection of dual reactive antibodies.

E Notidis1, S Hande, T Manser.   

Abstract

We investigated the role of apoptosis in the development of B cell memory by analyzing the (p-azophenylarsonate) Ars response in a line of A strain mice in which expression of human Bcl-2 was enforced in the B cell compartment. Previous studies of the Ars immune response in these A. Bcl-2 mice, demonstrated that a large percentage of the antibodies expressed by the Ars induced memory B cell compartment had accumulated point mutations via somatic hypermutation that increased their affinity for both Ars and the autoantigen DNA ("dual reactive" antibodies). This was in sharp contrast to normal A strain mice which displayed no dual reactive B cells in their Ars induced memory B cell compartment. These data suggested that interference with apoptotic pathways regulated by Bcl-2 allows developing memory B cells that have acquired autoreactivity to bypass a peripheral tolerance checkpoint. Further studies of these mice, reported here, demonstrate that enforced expression of Bcl-2 does not alter serum antibody affinity maturation nor positive selection of B cells expressing somatically mutated antibody with an increased affinity for Ars. Moreover, the somatic hypermutation process was unaffected in A. Bcl-2 mice. Thus, enforced expression of Bcl-2 in A. Bcl-2 mice appears to selectively alter a negative selection process that operates during memory B cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11785672      PMCID: PMC2276081          DOI: 10.1155/2001/83595

Source DB:  PubMed          Journal:  Dev Immunol        ISSN: 1026-7905


  4 in total

Review 1.  Activation-induced cytidine deaminase and aberrant germinal center selection in the development of humoral autoimmunities.

Authors:  Ahmad Zaheen; Alberto Martin
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

2.  Enforced expression of the apoptosis inhibitor Bcl-2 ablates tolerance induction in DNA-reactive B cells through a novel mechanism.

Authors:  Ying-Hua Wang; Yi Yan; Jeffrey S Rice; Bruce T Volpe; Betty Diamond
Journal:  J Autoimmun       Date:  2011-04-01       Impact factor: 7.094

3.  An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular Vulnerabilities.

Authors:  Ruth Flümann; Tim Rehkämper; Pascal Nieper; Hans Christian Reinhardt; Gero Knittel; Pauline Pfeiffer; Alessandra Holzem; Sebastian Klein; Sanil Bhatia; Moritz Kochanek; Ilmars Kisis; Benedikt W Pelzer; Heinz Ahlert; Julia Hauer; Alexandra da Palma Guerreiro; Jeremy A Ryan; Maurice Reimann; Arina Riabinska; Janica Wiederstein; Marcus Krüger; Martina Deckert; Janine Altmüller; Andreas R Klatt; Lukas P Frenzel; Laura Pasqualucci; Wendy Béguelin; Ari M Melnick; Sandrine Sander; Manuel Montesinos-Rongen; Anna Brunn; Philipp Lohneis; Reinhard Büttner; Hamid Kashkar; Arndt Borkhardt; Anthony Letai; Thorsten Persigehl; Martin Peifer; Clemens A Schmitt
Journal:  Blood Cancer Discov       Date:  2021-01

4.  Cooperation of ETV6/RUNX1 and BCL2 enhances immunoglobulin production and accelerates glomerulonephritis in transgenic mice.

Authors:  Eva Bauer; Michaela Schlederer; Ruth Scheicher; Jaqueline Horvath; Petra Aigner; Ana-Iris Schiefer; Renate Kain; Heinz Regele; Gregor Hoermann; Günter Steiner; Lukas Kenner; Veronika Sexl; Andreas Villunger; Richard Moriggl; Dagmar Stoiber
Journal:  Oncotarget       Date:  2016-03-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.